Adana Llanos, PhD, MPH, discusses the latest in breast cancer inequities following the American Cancer Society (ACS) biennial update of breast cancer statistics among women in the United States.
Arith Reyes, MD, shares the latest research on breast cancer patients who opted for breast-conservation surgery, such as lumpectomy, and those who underwent mastectomies.
Dr. Katja Pinker-Domenig, chief of the Division of Breast Imaging at NYP/CUIMC shares how mammograms, ultrasounds and MRIs are used to help detect and prevent breast cancer.
Breastfeeding has extensive health benefits to mother and child during postpartum nursing, but also offer long-term protection against breast cancer overtime.
Melissa Accordino, MD, tackles solutions to long-term side effects, like peripheral neuropathy, that some breast cancer survivors experience after overcoming the disease.
While medical experts agree that women should all get screened, the age at which screening should begin is an area of controversy, leaving patients confused as to what they should do.
Nearly half of all women have dense breasts. But many are not aware that having dense breasts comes with an elevated risk of breast cancer and that they could benefit from additional imaging tests.
Elaine Alden shares her story of overcoming triple-negative breast cancer with the hope of helping and supporting other patients and their families who are affected by cancer.
Researchers from the Herbert Irving Comprehensive Cancer Center presented new research on breast cancer risk prediction at the 2021 San Antonio Breast Cancer Symposium.
Sharon Howell had an encouraging response as a patient in the I-SPY clinical trials, and the outcome could also translate to a lower likelihood of her cancer coming back in the future.
Desiree Walker is dedicated to patient advocacy, driving awareness, community outreach engagement, empowering cancer patients, and linking them to the resources they need during treatment and beyond.
The 2021 Real-World Data Impact Award will support the researchers' work into the toxicity and efficacy of oral anticancer drugs and identifying disparities in care.
The 2021 Giants of Cancer Care inductees are leading researchers and educators whose discoveries have propelled the field of oncology forward and established the building blocks for future advances.